Mechanisms of the Antineoplastic Effects of New Fluoroquinolones in 2D and 3D Human Breast and Bladder Cancer Cell Lines
Authors:
Open Access
Abstract
Antibacterial fluoroquinolones have emerged as potential anticancer drugs, thus prompting the synthesis of novel molecules with improved cytotoxic characteristics. Ciprofloxacin and norfloxacin derivatives, previously synthesized by our group, showed higher anticancer potency than their progenitors. However, no information about their mechanisms of action was reported. In this study, we selected the most active among these promising molecules and evaluated, on a panel of breast (including those triple-negative) and bladder cancer cell lines, their ability to induce cell cycle alterations and apoptotic and necrotic cell death through cytofluorimetric studies. Furthermore, inhibitory effects on cellular migration, metalloproteinase, and/or acetylated histone protein levels were also evaluated by the scratch/wound healing assay and Western blot analyses, respectively. Finally, the DNA relaxation assay was performed to confirm topoisomerase inhibition. Our results indicate that the highest potency previously observed for the derivatives could be related to their ability to induce G2/M cell cycle arrest and apoptotic and/or necrotic cell death. Moreover, they inhibited cellular migration, probably by reducing metalloproteinase levels and histone deacetylases. Finally, topoisomerase inhibition, previously observed in silico, was confirmed. In conclusion, structural modifications of progenitor fluoroquinolones resulted in potent anticancer derivatives possessing multiple mechanisms of action, potentially exploitable for the treatment of aggressive/resistant cancers.Keywords
This publication has 70 references indexed in Scilit:
- Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial AgentsChemical Reviews, 2005
- Antitumor activity of common antibiotics against superficial bladder cancerUrology, 2004
- Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosisInternational Journal of Oncology, 2003
- Safety and tolerability of fluoroquinolonesClinical Cornerstone, 2003
- Urinary tract infection: traditional pharmacologic therapiesThe American Journal of Medicine, 2002
- Clinical toxicological aspects of fluoroquinolonesToxicology Letters, 2002
- Adverse Reactions to Fluoroquinolones. An Overview on Mechanistic AspectsCurrent Medicinal Chemistry, 2001
- Fluoroquinolone Toxicity Profiles: A Review Focusing on Newer AgentsClinical Infectious Diseases, 1999
- 4‐Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cellsJournal of Cellular Biochemistry, 1993
- EVALUATION OF A SOLUBLE TETRAZOLIUM FORMAZAN ASSAY FOR CELL-GROWTH AND DRUG SENSITIVITY IN CULTURE USING HUMAN AND OTHER TUMOR-CELL LINES1988